20 November 2026 re-tender around October 2026 |
Antiandrogenios - apalutamida - 3 meses
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) framework agreement |
JANSSEN CILAG FARMACEUTICA, LDA 1 bid received |
€291,438 |
21 November 2026 re-tender around October 2026 |
2023/0491 - Ibrutinib [140 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€234,620 |
21 November 2026 re-tender around October 2026 |
2023/0491 - Ibrutinib [560 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€454,109 |
5 December 2026 re-tender around October 2026 |
2025/1589 - Teclistamab [90 mg/ml 1,7 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€543,665 |
7 December 2026 re-tender around October 2026 |
2023/0491 - Guselcumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€74,214 |
8 December 2026 re-tender around October 2026 |
2023/0491 - Guselcumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€9,895 |
21 December 2026 re-tender around October 2026 |
2023/0491 - Guselcumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€247,380 |
21 December 2026 re-tender around October 2026 |
2023/0491 - Daratumumab [120 mg/ ml 15 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€6,945,039 |
21 December 2026 re-tender around October 2026 |
2023/0491 - Ibrutinib [420 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€2,243,289 |
21 December 2026 re-tender around October 2026 |
2024/0961 - Apalutamida [240 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€403,696 |
21 December 2026 re-tender around October 2026 |
2024/0961 - Apalutamida [240 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€1,284,486 |
21 December 2026 re-tender around October 2026 |
2024/0900 - Darunavir + cobicistate + emtricitabina + tenofovir alafenamida [800 + 150 + 200 + 10 mg comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€561,926 |
21 December 2026 re-tender around October 2026 |
2025/1627 - Macitentano [10 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€562,200 |
21 December 2026 re-tender around October 2026 |
2024/0900 - Darunavir + cobicistate [800 mg + 150 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€753,976 |
30 December 2026 re-tender around October 2026 |
Imunomoduladores - daratumumab - 3 meses
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) framework agreement |
JANSSEN CILAG FARMACEUTICA, LDA 1 bid received |
€458,281 |
30 December 2026 re-tender around October 2026 |
Antiviricos - 3 meses
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) framework agreement |
JANSSEN CILAG FARMACEUTICA, LDA 1 bid received |
€284,160 |
7 January 2027 re-tender around October 2026 |
2023/0491 - Ibrutinib [140 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€52,979 |
7 January 2027 re-tender around October 2026 |
2023/0491 - Daratumumab [120 mg/ ml 15 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€2,499,714 |
7 January 2027 re-tender around October 2026 |
2023/0491 - Ibrutinib [420 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€590,339 |
8 January 2027 re-tender around October 2026 |
2025/1627 - Macitentano [10 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€168,660 |
12 January 2027 re-tender around October 2026 |
2025/1589 - Ciltacabtagene autoleucel [3.2 x10e6 - 1.0 x10e8 células disp perf saco]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€400,596 |
13 January 2027 re-tender around October 2026 |
2025/1589 - Golimumab [50 mg/0.5 ml sol inj caneta/seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€71,429 |
20 January 2027 re-tender around October 2026 |
2025/1589 - Ciltacabtagene autoleucel [3.2 x10e6 - 1.0 x10e8 células disp perf saco]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
JANSSEN-CILAG FARMACEUTICA LDA 1 bid received |
€400,596 |